NCT00208273View on ClinicalTrials.gov

Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

February 28, 2007

Conditions
Breast Cancer
Interventions
DRUG

Letrozole - Concomitant

DRUG

Letrozole - Sequential

Trial Locations (1)

34298

CRLC Val d'Aurelle, Montpellier

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT00208273 - Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer | Biotech Hunter | Biotech Hunter